Literature DB >> 20703219

Inherited human diseases of heterotopic bone formation.

Eileen M Shore1, Frederick S Kaplan.   

Abstract

Human disorders of hereditary and nonhereditary heterotopic ossification are conditions in which osteogenesis occurs outside of the skeleton, within soft tissues of the body. The resulting extraskeletal bone is normal. The aberration lies within the mechanisms that regulate cell-fate determination, directing the inappropriate formation of cartilage or bone, or both, in tissues such as skeletal muscle and adipose tissue. Specific gene mutations have been identified in two rare inherited disorders that are clinically characterized by extensive and progressive extraskeletal bone formation-fibrodysplasia ossificans progressiva and progressive osseous heteroplasia. In fibrodysplasia ossificans progressiva, activating mutations in activin receptor type-1, a bone morphogenetic protein type I receptor, induce heterotopic endochondral ossification, which results in the development of a functional bone organ system that includes skeletal-like bone and bone marrow. In progressive osseous heteroplasia, the heterotopic ossification leads to the formation of mainly intramembranous bone tissue in response to inactivating mutations in the GNAS gene. Patients with these diseases variably show malformation of normal skeletal elements, identifying the causative genes and their associated signaling pathways as key mediators of skeletal development in addition to regulating cell-fate decisions by adult stem cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20703219      PMCID: PMC3551620          DOI: 10.1038/nrrheum.2010.122

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  95 in total

Review 1.  Neurogenic heterotopic ossification in spinal cord injury.

Authors:  A A van Kuijk; A C H Geurts; H J M van Kuppevelt
Journal:  Spinal Cord       Date:  2002-07       Impact factor: 2.772

2.  A form of Jansen's metaphyseal chondrodysplasia with limited metabolic and skeletal abnormalities is caused by a novel activating parathyroid hormone (PTH)/PTH-related peptide receptor mutation.

Authors:  Murat Bastepe; Annick Raas-Rothschild; Justin Silver; Irit Weissman; Shlomo Wientroub; Harald Jüppner; David Gillis
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

3.  Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP).

Authors:  Jennifer L Fiori; Paul C Billings; Lourdes Serrano de la Peña; Frederick S Kaplan; Eileen M Shore
Journal:  J Bone Miner Res       Date:  2006-06       Impact factor: 6.741

Review 4.  Heterotopic ossification: a review.

Authors:  E F McCarthy; M Sundaram
Journal:  Skeletal Radiol       Date:  2005-08-25       Impact factor: 2.199

5.  Differentiation plasticity regulated by TGF-beta family proteins in development and disease.

Authors:  Rik Derynck; Rosemary J Akhurst
Journal:  Nat Cell Biol       Date:  2007-09       Impact factor: 28.824

Review 6.  GNAS locus and pseudohypoparathyroidism.

Authors:  Murat Bastepe; Harald Jüppner
Journal:  Horm Res       Date:  2005-02-09

7.  The imprinted signaling protein XL alpha s is required for postnatal adaptation to feeding.

Authors:  Antonius Plagge; Emma Gordon; Wendy Dean; Romina Boiani; Saverio Cinti; Jo Peters; Gavin Kelsey
Journal:  Nat Genet       Date:  2004-07-25       Impact factor: 38.330

8.  ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development.

Authors:  Donghui Zhang; Edward M Schwarz; Randy N Rosier; Michael J Zuscik; J Edward Puzas; Regis J O'Keefe
Journal:  J Bone Miner Res       Date:  2003-09       Impact factor: 6.741

9.  Heterotopic ossification in high-energy wartime extremity injuries: prevalence and risk factors.

Authors:  Jonathan Agner Forsberg; Joseph M Pepek; Scott Wagner; Kevin Wilson; James Flint; Romney C Andersen; Doug Tadaki; Frederick A Gage; Alexander Stojadinovic; Eric A Elster
Journal:  J Bone Joint Surg Am       Date:  2009-05       Impact factor: 5.284

10.  cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin.

Authors:  Der-Chih Yang; Huey-Jen Tsay; Shan-Yang Lin; Shih-Hwa Chiou; Mei-Jane Li; Tai-Jay Chang; Shih-Chieh Hung
Journal:  PLoS One       Date:  2008-02-06       Impact factor: 3.240

View more
  102 in total

1.  Fibrodysplasia ossificans progressiva: a human genetic disorder of extraskeletal bone formation, or--how does one tissue become another?

Authors:  Eileen M Shore
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012 Jan-Feb       Impact factor: 5.814

Review 2.  Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva.

Authors:  Emilie Barruet; Edward C Hsiao
Journal:  Bone       Date:  2017-07-14       Impact factor: 4.398

3.  Somitic disruption of GNAS in chick embryos mimics progressive osseous heteroplasia.

Authors:  Dana M Cairns; Robert J Pignolo; Tomoya Uchimura; Tracy A Brennan; Carter M Lindborg; Meiqi Xu; Frederick S Kaplan; Eileen M Shore; Li Zeng
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

4.  Heterozygous inactivation of Gnas in adipose-derived mesenchymal progenitor cells enhances osteoblast differentiation and promotes heterotopic ossification.

Authors:  Robert J Pignolo; Meiqi Xu; Elizabeth Russell; Alec Richardson; Josef Kaplan; Paul C Billings; Frederick S Kaplan; Eileen M Shore
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

5.  Sensory nerve induced inflammation contributes to heterotopic ossification.

Authors:  Elizabeth Salisbury; Eric Rodenberg; Corinne Sonnet; John Hipp; Francis H Gannon; Tegy J Vadakkan; Mary E Dickinson; Elizabeth A Olmsted-Davis; Alan R Davis
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

6.  Apyrase as a novel therapeutic inhibitor of heterotopic ossification.

Authors:  Olin D Liang; Anthony M Reginato; Damian Medici
Journal:  Ann Transl Med       Date:  2015-05

7.  Clinical Utility Gene Card for: Fibrodysplasia ossificans progressiva.

Authors:  Nathalie Bravenboer; Dimitra Micha; James T Triffit; Alex N Bullock; Roberto Ravazollo; Renata Bocciardi; Maja di Rocco; J Coen Netelenbos; Peter Ten Dijke; Gonzalo Sánchez-Duffhues; Fred S Kaplan; Eileen M Shore; Robert J Pignolo; Petra Seemann; Francesc Ventura; Genevieve Beaujat; Elizabeth M W Eekhoff; Gerard Pals
Journal:  Eur J Hum Genet       Date:  2015-01-21       Impact factor: 4.246

Review 8.  Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis.

Authors:  Frederick S Kaplan; Mona Al Mukaddam; Alexandra Stanley; O Will Towler; Eileen M Shore
Journal:  Bone       Date:  2020-07-27       Impact factor: 4.398

9.  Mkx-Deficient Mice Exhibit Hedgehog Signaling-Dependent Ectopic Ossification in the Achilles Tendons.

Authors:  Han Liu; Jingyue Xu; Rulang Jiang
Journal:  J Bone Miner Res       Date:  2019-02-25       Impact factor: 6.741

10.  Different roles of GNAS and cAMP signaling during early and late stages of osteogenic differentiation.

Authors:  S Zhang; F S Kaplan; E M Shore
Journal:  Horm Metab Res       Date:  2012-08-17       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.